Stay updated on Nivolumab vs Bevacizumab in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Bevacizumab in Glioblastoma Clinical Trial page.

Latest updates to the Nivolumab vs Bevacizumab in Glioblastoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2. No substantive study details appear to have changed.SummaryDifference0.0%

- Check21 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and updated the revision to v3.3.1.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoved the general operating-status notice about funding lapse and NIH operations, which is not part of the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check43 days agoChange DetectedThe new screenshot shows minor UI/layout adjustments on the study details page with no changes to core content such as the study title, eligibility criteria, or trial arms. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check72 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference2%

- Check79 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Nivolumab vs Bevacizumab in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Bevacizumab in Glioblastoma Clinical Trial page.